Summary: Donation of CCP, Blood Components and HCT/Ps, Including Information on COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 04/14/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
July 19, 2024
REGULATORY UPDATE: FDA Issues New Guidance on Donor Blood Pressure and Pulse Requirements
July 17, 2024
Czech Republic Introduces Individual Donor Assessment
July 10, 2024